Dr. Reddy's Laboratories Ltd. (RDY,DRREDDY) announced Thursday the launch of Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets.
It is a therapeutic equivalent generic version of Renvela (sevelamer carbonate) for Oral Suspension, approved by the U.S. Food and Drug Administration.
Renvela is a trademark of French drug giant Sanofi (SNYNF,SNY).
Dr. Eddy's noted that the Renvela brand and generic had U.S. sales of approximately $101 million MAT for the most recent twelve months ending in October 2018, according to IMS Health.
Dr. Reddy's Sevelamer Carbonate for Oral Suspension is available in 0.8 g and 2.4 g packets in count size of 90.
For comments and feedback contact: editorial@rttnews.com
Business News